DOCSLIB.ORG

YY1 Plays an Essential Role at All Stages of B-Cell Differentiation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
YY1 Plays an Essential Role at All Stages of B-Cell Differentiation YY1 plays an essential role at all stages of PNAS PLUS B-cell differentiation Eden Kleimana,1, Haiqun Jiaa,1,2, Salvatore Loguerciob,1, Andrew I. Sub, and Ann J. Feeneya,3 aDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037; and bDepartment of Molecular Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037 Edited by Max D. Cooper, Emory University, Atlanta, GA, and approved May 16, 2016 (received for review April 25, 2016) Ying Yang 1 (YY1) is a ubiquitously expressed transcription factor single DJ rearrangement to create a maximally diverse antibody shown to be essential for pro–B-cell development. However, the repertoire using the potential germ-line diversity afforded by role of YY1 in other B-cell populations has never been investi- the >100 functional Vh genes. This equal access is accomplished gated. Recent bioinformatics analysis data have implicated YY1 through the process of locus contraction, in which the entire Vh in the germinal center (GC) B-cell transcriptional program. In accord portion of the large 2.8-Mb Igh locus contracts, as determined by with this prediction, we demonstrated that deletion of YY1 by Cγ1- 3D-FISH analyses (14, 15), which results in making the distal Vh Cre completely prevented differentiation of GC B cells and plasma genes equally as close to the DJ rearrangement as the proximal cells. To determine if YY1 was also required for the differentiation Vh genes. Unlike wild-type pro-B cells, YY1-deficient pro-B of other B-cell populations, we deleted YY1 with CD19-Cre and cells do not undergo locus contraction (13). They are also unable to rearrange distal Vh genes, whereas the most proximal two Vh found that all peripheral B-cell subsets, including B1 B cells, require families rearrange at almost normal levels, which may be due to YY1 for their differentiation. Transitional 1 (T1) B cells were the defective locus contraction. When the Igh locus is poised for most dependent upon YY1, being sensitive to even a half-dosage rearrangement, there is noncoding transcription of unrearranged of YY1 and also to short-term YY1 deletion by tamoxifen-induced V and J genes, as well as intergenic antisense transcription. All of Cre. We show that YY1 exerts its effects, in part, by promoting B-cell the V region sense and antisense germ-line transcripts that we − − survival and proliferation. ChIP-sequencing shows that YY1 predom- assayed in that study were found to be greatly reduced in YY1 / inantly binds to promoters, and pathway analysis of the genes that pro-B cells, especially the very prominent antisense transcripts bind YY1 show enrichment in ribosomal functions, mitochondrial within the distal part of the Vh locus at the Pax5-activated INFLAMMATION IMMUNOLOGY AND functions such as bioenergetics, and functions related to transcrip- intergenic repeat (PAIR) elements (16). We have hypothesized tion such as mRNA splicing. By RNA-sequencing analysis of differ- that this noncoding RNA in the Vh locus is at least partially entially expressed genes, we demonstrated that YY1 normally responsible for locus contraction, because we showed by chro- activates genes involved in mitochondrial bioenergetics, whereas mosome conformation capture (3C) that the promoters of the it normally down-regulates genes involved in transcription, mRNA most prominent noncoding RNA within the distal Igh locus, splicing, NF-κB signaling pathways, the AP-1 transcription factor PAIR elements, make direct contact with the region near DJ, network, chromatin remodeling, cytokine signaling pathways, cell presumably within a common transcription factory (16). In ad- adhesion, and cell proliferation. Our results show the crucial role dition, 3D-FISH and 3C demonstrate decreased interaction of that YY1 plays in regulating broad general processes throughout two sites in the middle and distal parts of the Igh locus with Eμ all stages of B-cell differentiation. after YY1 knockdown (17). Therefore, the lack of locus contraction YY1 | B lymphocytes | differentiation | mitochondrial bioenergetics | Significance transcription Ying Yang 1 (YY1) is a ubiquitously expressed transcription ing Yang 1 (YY1) is a ubiquitously expressed zinc finger- factor that has been demonstrated to be essential for pro–B-cell Ycontaining transcription factor that was given its name due development as well as lymphoma. It has recently been pro- to the ability to repress or activate transcription (1). YY1 was posed that YY1 regulates the germinal center B-cell transcrip- first identified in 1991 as being a key regulator for several viral tional program. We confirm this hypothesis and additionally genes, as well as a repressor of the Ig 3′κ-enhancer (1–5). YY1 show that YY1 is equally essential for all stages of B-cell differ- can activate or repress genes by recruiting a variety of coactivators entiation. Through ChIP-sequencing analysis of YY1 binding, and or corepressors. It can recruit several histone-modifying com- analysis of differentially expressed genes from RNA-sequencing, plexes, including those containing histone acetyltransferases or our data show that, in addition to the regulation of several histone deacetylases, thus resulting in opposing epigenetic profiles B-cell–specific genes, YY1 regulates many genes and pathways (6, 7). It is highly conserved from Xenopus to humans, and there is important in basic cellular functions, such as mitochondrial bio- even a Drosophila ortholog of YY1. YY1 has also been implicated energetics, transcription, ribosomal function, and cellular pro- in Polycomb-mediated repression (8), and it has strong homology liferation, thus explaining the requirement for YY1 at all stages to Pho, the DNA binding recruiter of Polycomb-repressive com- of B-cell differentiation. plexes in Drosophila (9, 10). Pho also plays an important role in embryonic patterning in Drosophila.InXenopus, YY1 also is im- Author contributions: E.K., H.J., and A.J.F. designed research; E.K. and H.J. performed research; E.K., H.J., S.L., A.I.S., and A.J.F. analyzed data; and E.K. and A.J.F. wrote portant in patterning and neural induction (11). Not surprisingly the paper. therefore, germ-line deletion of YY1 leads to embryonic lethality The authors declare no conflict of interest. at the periimplantation stage (12). Within the B lineage of lymphocytes, YY1 was shown to play This article is a PNAS Direct Submission. critical roles at the pro–B-cell stage of differentiation. Condi- Data deposition: The data reported in this paper have been deposited in the Gene Ex- tional deletion of YY1 with mb1-Cre resulted in a block at the pression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE73534). pro–B-cell to pre–B-cell stage (13). In pro-B cells, the Igh locus 1E.K., H.J., and S.L. contributed equally to this work. undergoes V(D)J rearrangement. D-to-J gene rearrangement 2Present address: California Institute for Biomedical Research (Calibr), La Jolla, CA 92037. occurs first on both alleles, followed by V-to-DJ rearrangement 3To whom correspondence should be addressed. Email: [email protected]. on one allele. Because only one V-to-DJ rearrangement is allowed This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. on each allele, all V genes should have equivalent access to the 1073/pnas.1606297113/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1606297113 PNAS Early Edition | 1of10 Downloaded by guest on September 26, 2021 transcriptional signatures of genes specific for each stage of nor- mal B-cell differentiation (19). The bioinformatic analysis of the signature genes for each stage showed that only the GC B-cell signature genes had a significant enrichment for YY1 binding motifs, and thus the authors concluded that YY1 was a regulator of the GC B-cell–specific transcriptional program. Furthermore, using an in vitro class switch culture system, it has been demon- strated that YY1 interacts with activation-induced cytidine de- aminase (AID) and increases AID nuclear stability (20). AID is activated in GC B cells to carry out SHM and CSR, thus providing an additional potential role for YY1 during in vivo GC B-cell development. If YY1 were indeed a critical regulator of GC B-cell dif- ferentiation, then we predicted that a GC-specific deletion of YY1 should ablate the ability of naive B cells to become GC Fig. 1. YY1 deletion prevents the differentiation of naive B cells into GC B + f/f × γ B cells. Here, we present data showing that conditional de- cells, PCs, and IgG1 isotype-switched cells. YY1 C 1-Cre mice were im- letion of YY1 in B cells with Cγ1-Cre within 2 d after anti- munized with OVA/LPS/alum. Splenic B-cell populations from immunized gen activation does indeed prevent the appearance of GC mice and unimmunized controls were analyzed by flow cytometry 8 d after immunization. YY1 deletion prevented the differentiation of naive B cells B cells after antigen stimulation. To determine if YY1 was + into GC B cells (A), PCs (B), and IgG1 B cells (C). Values from individual mice only critical for the differentiation of GC B cells, we analyzed are displayed, and they are derived from a total of four experiments. ***P < mice in which YY1 was deleted by CD19-Cre, which deletes 0.0001. NS, not significant. in the late BM stage. These mice showed that, unlike the prediction based on the bioinformatic analysis of B-signature genes, YY1 is required for every stage of B-cell maturation. and lack of rearrangement of distal Vh genes in YY1-deficient Analysis of genes that bound YY1 in ChIP-sequencing (ChIP- pro-B cells may be due, in part, to a lack of noncoding antisense seq) at four stages of differentiation and comparison of the RNA in the distal part of the Vh region and to a lack of YY1- RNA-sequencing (RNA-seq) gene expression profile of pro- dependent long-range interactions.
Load more

Recommended publications
  • NIH Public Access Author Manuscript Immunogenetics
    NIH Public Access Author Manuscript Immunogenetics. Author manuscript; available in PMC 2013 August 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Immunogenetics. 2012 August ; 64(8): 647–652. doi:10.1007/s00251-012-0626-0. A VpreB3 homologue from a marsupial, the gray short-tailed opossum, Monodelphis domestica Xinxin Wang, Zuly E. Parra, and Robert D. Miller Center for Evolutionary & Theoretical Immunology, Department of Biology, University of New Mexico, Albuquerque, NM, 87131, USA Robert D. Miller: [email protected] Abstract A VpreB surrogate light (SL) chain was identified for the first time in a marsupial, the opossum Monodelphis domestica. Comparing the opossum VpreB to homologues from eutherian (placental mammals) and avian species supported the marsupial gene being VpreB3. VpreB3 is a protein that is not known to traffic to the cell surface as part of the pre-B cell receptor. Rather, VpreB3 associates with nascent immunoglobulin (Ig) chains in the endoplasmic reticulum. Homologues of other known SL chains VpreB1, VpreB2, and λ5, which are found in eutherian mammals, were not found in the opossum genome, nor have they been identified in the genomes of non-mammals. VpreB3 likely evolved from earlier gene duplication, independent of that which generated VpreB1 and VpreB2 in eutherians. The apparent absence of VpreB1, VpreB2, and λ5 in marsupials suggests that an extra-cellular pre-B cell receptor containing SL chains, as it has been defined in humans and mice, may be unique to eutherian mammals. In contrast, the conservation of VpreB3 in marsupials and its presence in non-mammals is consistent with previous hypotheses that it is playing a more primordial role in B cell development.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Poised Lineage Specification in Multipotential Hematopoietic Stem
    Cell Stem Cell Short Article Poised Lineage Specification in Multipotential Hematopoietic Stem and Progenitor Cells by the Polycomb Protein Bmi1 Hideyuki Oguro,1,2 Jin Yuan,1,2 Hitoshi Ichikawa,4 Tomokatsu Ikawa,5 Satoshi Yamazaki,3,6 Hiroshi Kawamoto,5 Hiromitsu Nakauchi,3,6 and Atsushi Iwama1,2,* 1Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan 2JST, CREST 3JST, ERATO Sanbancho, Chiyoda-ku, Tokyo 102-0075, Japan 4Genetics Division, National Cancer Center Research Institute, Tokyo, 104-0045, Japan 5Laboratory for Lymphocyte Development, RIKEN Research Center for Allergy and Immunology, Yokohama 230-0045, Japan 6Laboratory of Stem Cell Therapy, Center for Experimental Medicine, Institute of Medical Sciences, University of Tokyo, Tokyo 108-8679, Japan *Correspondence: [email protected] DOI 10.1016/j.stem.2010.01.005 SUMMARY Pietersen and van Lohuizen, 2008). They reside in two main complexes, termed Polycomb repressive complex 1 and 2 Polycomb group (PcG) proteins are essential regula- (PRC1 and PRC2). PRC2 and trithorax group (trxG) proteins tors of stem cells. PcG and trithorax group proteins mark developmental regulator gene promoters with bivalent mark developmental regulator gene promoters with domains consisting of overlapping repressive and activating bivalent domains consisting of overlapping repres- histone modifications to keep developmental regulators sive and activating histone modifications to keep ‘‘poised’’ for activation in embryonic stem cells (ESCs) (Bernstein them poised for activation in embryonic stem cells. et al., 2006; Spivakov and Fisher 2007; Mendenhall and Bern- stein, 2008). Likewise, in adult stem cells, developmental regula- Bmi1, a component of PcG complexes, maintains tors that govern lineage specification are supposedly repressed the self-renewal capacity of adult stem cells, but its epigenetically to maintain their multipotency (Pietersen and van role in multipotency remains obscure.
    [Show full text]
  • A Second Gene, Vpreb in the X5 Locus of the Mouse, Which Appears to Be Selectively Expressed in Pre-B Lymphocytes
    The EMBO Journal vol.6 no.8 pp.2267-2272, 1987 A second gene, VpreB in the X5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes Akira Kudo and Fritz Melchers respectively. Exon I shows no strong homology to any known Basel Institute for Immunology, Postfach, CH-4058 Grenzacherstrasse 487, gene. The putative protein encoded by the X5 gene, although not Basel, Switzerland yet identified, is a potential candidate for heterodimer formation Communicated by F.Melchers with IgH chains and thereby, may influence the function which H chains play in pre-B cell development. We describe here, The murine gene X5 is selectively expressed in pre-B lym- 4.6 kb upstream of X5 another gene named VpreB1 composed of phocytes. Of the three exons encoding X5, exons II and III two exons which is selectively expressed in pre-B cell lines as show strong homologies to immunoglobulin X light (L) chain 0.85 kb mRNA. The putative protein encoded by this gene is gene segments, i.e. to Jx intron and exon, and Cx exon se- a potential candidate for association with the X5 protein and quences respectively. We have now found, 4.6 kb upstream may, therefore, also influence the role of H chains in pre-B cell of X5, another gene composed of two exons which is selec- development. tively expressed in pre-B cell lines as a 0.85 kb mRNA poten- tially coding for a protein of 142 amino acids including a 19 Results amino acid-long signal peptide.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Flow Reagents Single Color Antibodies CD Chart
    CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n
    [Show full text]
  • CDH12 Cadherin 12, Type 2 N-Cadherin 2 RPL5 Ribosomal
    5 6 6 5 . 4 2 1 1 1 2 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 A A A A A A A A A A A A A A A A A A A A C C C C C C C C C C C C C C C C C C C C R R R R R R R R R R R R R R R R R R R R B , B B B B B B B B B B B B B B B B B B B , 9 , , , , 4 , , 3 0 , , , , , , , , 6 2 , , 5 , 0 8 6 4 , 7 5 7 0 2 8 9 1 3 3 3 1 1 7 5 0 4 1 4 0 7 1 0 2 0 6 7 8 0 2 5 7 8 0 3 8 5 4 9 0 1 0 8 8 3 5 6 7 4 7 9 5 2 1 1 8 2 2 1 7 9 6 2 1 7 1 1 0 4 5 3 5 8 9 1 0 0 4 2 5 0 8 1 4 1 6 9 0 0 6 3 6 9 1 0 9 0 3 8 1 3 5 6 3 6 0 4 2 6 1 0 1 2 1 9 9 7 9 5 7 1 5 8 9 8 8 2 1 9 9 1 1 1 9 6 9 8 9 7 8 4 5 8 8 6 4 8 1 1 2 8 6 2 7 9 8 3 5 4 3 2 1 7 9 5 3 1 3 2 1 2 9 5 1 1 1 1 1 1 5 9 5 3 2 6 3 4 1 3 1 1 4 1 4 1 7 1 3 4 3 2 7 6 4 2 7 2 1 2 1 5 1 6 3 5 6 1 3 6 4 7 1 6 5 1 1 4 1 6 1 7 6 4 7 e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e e l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p p m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m m
    [Show full text]
  • A Promising Marker of Hormone Refractory Metastatic Prostate Cancer
    Vol. 11, 2237–2243, March 15, 2005 Clinical Cancer Research 2237 Reg IV: A Promising Marker of Hormone Refractory Metastatic Prostate Cancer Zhennan Gu,2 Mark A. Rubin,4 Yu Yang,4 growing tumors that may not impact an individual’s natural life Samuel E. Deprimo,5 Hongjuan Zhao,5 span, although others are struck by rapidly progressive, metastatic tumors. Prostate-specific antigen screening is limited by a lack of Steven Horvath,1 James D. Brooks,5 4 2,3 specificity and an inability to predict which patients are at risk to Massimo Loda, and Robert E. Reiter develop hormone refractory metastatic disease. Recent studies Departments of 1Statistics and 2Urology, and the 3Molecular Biology advocating a lower prostate-specific antigen threshold for Institute, Geffen School of Medicine at University of California at diagnosis may increase the number of prostate cancer diagnoses Los Angeles, Los Angeles, California; 4Department of Pathology, Dana-Farber Cancer Institute, Harvard School of Medicine, Boston, and further complicate the identification of patients with indolent Massachusetts; and 5Department of Urology, Stanford University versus aggressive cancers (1). New serum and tissue markers that School of Medicine, Stanford, California correlate with clinical outcome or identify patients with potentially aggressive disease are urgently needed (2). Recent expression profiling studies suggest that expression ABSTRACT signatures for metastatic versus nonmetastatic tumors may reside The diagnosis and management of prostate cancer is in the primary tumor (2–4). Additional features that predispose hampered by the absence of markers capable of identifying tumors to metastasize to specific organs may also be present at patients with metastatic disease.
    [Show full text]
  • Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association Between BMI and Adult-Onset Non- Atopic
    Supplementary Material DNA Methylation in Inflammatory Pathways Modifies the Association between BMI and Adult-Onset Non- Atopic Asthma Ayoung Jeong 1,2, Medea Imboden 1,2, Akram Ghantous 3, Alexei Novoloaca 3, Anne-Elie Carsin 4,5,6, Manolis Kogevinas 4,5,6, Christian Schindler 1,2, Gianfranco Lovison 7, Zdenko Herceg 3, Cyrille Cuenin 3, Roel Vermeulen 8, Deborah Jarvis 9, André F. S. Amaral 9, Florian Kronenberg 10, Paolo Vineis 11,12 and Nicole Probst-Hensch 1,2,* 1 Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; [email protected] (A.J.); [email protected] (M.I.); [email protected] (C.S.) 2 Department of Public Health, University of Basel, 4001 Basel, Switzerland 3 International Agency for Research on Cancer, 69372 Lyon, France; [email protected] (A.G.); [email protected] (A.N.); [email protected] (Z.H.); [email protected] (C.C.) 4 ISGlobal, Barcelona Institute for Global Health, 08003 Barcelona, Spain; [email protected] (A.-E.C.); [email protected] (M.K.) 5 Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain 6 CIBER Epidemiología y Salud Pública (CIBERESP), 08005 Barcelona, Spain 7 Department of Economics, Business and Statistics, University of Palermo, 90128 Palermo, Italy; [email protected] 8 Environmental Epidemiology Division, Utrecht University, Institute for Risk Assessment Sciences, 3584CM Utrecht, Netherlands; [email protected] 9 Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College, SW3 6LR London, UK; [email protected] (D.J.); [email protected] (A.F.S.A.) 10 Division of Genetic Epidemiology, Medical University of Innsbruck, 6020 Innsbruck, Austria; [email protected] 11 MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, W2 1PG London, UK; [email protected] 12 Italian Institute for Genomic Medicine (IIGM), 10126 Turin, Italy * Correspondence: [email protected]; Tel.: +41-61-284-8378 Int.
    [Show full text]
  • IGLL1 Polyclonal Antibody
    PRODUCT DATA SHEET Bioworld Technology,Inc. IGLL1 polyclonal antibody Catalog: BS65198 Host: Rabbit Reactivity: Human BackGround: Storage&Stability: immunoglobulin lambda like polypeptide 1(IGLL1) Ho- Store at 4°C short term. Aliquot and store at -20°C long mo sapiens The preB cell receptor is found on the surface term. Avoid freeze-thaw cycles. of proB and preB cells, where it is involved in transduc- Specificity: tion of signals for cellular proliferation, differentiation Lambda 5 Polyclonal Antibody detects endogenous levels from the proB cell to the preB cell stage, allelic exclusion of Lambda 5 protein. at the Ig heavy chain gene locus, and promotion of Ig DATA: light chain gene rearrangements. The preB cell receptor is composed of a membrane-bound Ig mu heavy chain in association with a heterodimeric surrogate light chain. This gene encodes one of the surrogate light chain subu- nits and is a member of the immunoglobulin gene super- family. This gene does not undergo rearrangement. Muta- tions in this gene can result in B cell deficiency and agammaglobulinemia, an autosomal recessive disease in Western Blot analysis of KB cells using Lambda 5 Polyclonal Anti- which few or no gamma globulins or antibodies are made. body.. Secondary antibody(catalog#：RS0002) was diluted at 1:20000 Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008], Product: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. Molecular Weight: ~ 23 kDa Swiss-Prot: Immunohistochemical analysis of paraffin-embedded human-lymph, P15814 antibody was diluted at 1:100 Purification&Purity: Note: The antibody was affinity-purified from rabbit antiserum For research use only, not for use in diagnostic procedure.
    [Show full text]